Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pacira BioSciences Inc.

    NASDAQ: PCRX · Real-Time Price · USD
    24.29
    0.05 (0.21%)
    At close: Jun 16, 2025, 3:59 PM
    24.34
    0.23%
    After-hours: Jun 16, 2025, 04:20 PM EDT

    Pacira BioSciences Statistics

    Share Statistics

    Pacira BioSciences has 46.3M shares outstanding. The number of shares has increased by -0.58% in one year.

    Shares Outstanding

    n/a
    		 46.3M

    Shares Change (YoY)

    n/a
    		 -0.58%

    Shares Change (QoQ)

    n/a
    		 0.22%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 44.31M

    Failed to Deliver (FTD) Shares

    n/a
    		 117

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 5.83M, so 12.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.83M

    Short % of Shares Out

    n/a
    		 12.6%

    Short % of Float

    n/a
    		 17.84%

    Short Ratio (days to cover)

    n/a
    		 8.11

    Valuation Ratios

    The PE ratio is -8.75 and the forward PE ratio is 7.07. Pacira BioSciences's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -8.75

    Forward PE

    n/a
    		 7.07

    PS Ratio

    n/a
    		 1.24

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 1.12

    P/FCF Ratio

    n/a
    		 4.87

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pacira BioSciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.4, with a Debt / Equity ratio of 0.82.

    Current Ratio

    n/a
    		 2.4

    Quick Ratio

    n/a
    		 2

    Debt / Equity

    n/a
    		 0.82

    Debt / EBITDA

    n/a
    		 19.81

    Debt / FCF

    n/a
    		 3.57

    Interest Coverage

    n/a
    		 -4.43

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $889,550.76

    Profits Per Employee

    n/a
    		 $-126,345.18

    Employee Count

    n/a
    		 788

    Asset Turnover

    n/a
    		 0.45

    Inventory Turnover

    n/a
    		 1.36

    Taxes

    Income Tax

    n/a
    		 36.45M

    Effective Tax Rate

    n/a
    		 -57.77%

    Stock Price Statistics

    The stock price has increased by -11.16% in the last 52 weeks. The beta is 0.51, so Pacira BioSciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.51

    52-Week Price Change

    n/a
    		 -11.16%

    50-Day Moving Average

    n/a
    		 25.45

    200-Day Moving Average

    n/a
    		 21.17

    Relative Strength Index (RSI)

    n/a
    		 39.84

    Average Volume (20 Days)

    n/a
    		 894,823

    Income Statement

    In the last 12 months, Pacira BioSciences had revenue of 700.97M and earned -99.56M in profits. Earnings per share was -2.15.

    Revenue

    n/a
    		 700.97M

    Gross Profit

    n/a
    		 530.54M

    Operating Income

    n/a
    		 -73.37M

    Net Income

    n/a
    		 -99.56M

    EBITDA

    n/a
    		 32.25M

    EBIT

    n/a
    		 -49.67M

    Earnings Per Share (EPS)

    n/a
    		 -2.15
    Full Income Statement

    Balance Sheet

    The company has 276.77M in cash and 638.85M in debt, giving a net cash position of -362.08M.

    Cash & Cash Equivalents

    n/a
    		 276.77M

    Total Debt

    n/a
    		 638.85M

    Net Cash

    n/a
    		 -362.08M

    Retained Earnings

    n/a
    		 -206.36M

    Total Assets

    n/a
    		 1.59B

    Working Capital

    n/a
    		 445.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 189.39M and capital expenditures -10.64M, giving a free cash flow of 178.75M.

    Operating Cash Flow

    n/a
    		 189.39M

    Capital Expenditures

    n/a
    		 -10.64M

    Free Cash Flow

    n/a
    		 178.75M

    FCF Per Share

    n/a
    		 3.87
    Full Cash Flow Statement

    Margins

    Gross margin is 75.69%, with operating and profit margins of -10.47% and -14.2%.

    Gross Margin

    n/a
    		 75.69%

    Operating Margin

    n/a
    		 -10.47%

    Pretax Margin

    n/a
    		 -9%

    Profit Margin

    n/a
    		 -14.2%

    EBITDA Margin

    n/a
    		 4.6%

    EBIT Margin

    n/a
    		 -10.47%

    FCF Margin

    n/a
    		 25.5%

    Dividends & Yields

    PCRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PCRX is $25, which is 2.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 2.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.39

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist